Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
| Autor: | Van Cutsem E, Vervenne WL, Bennouna J, Humblet Y, Gill S, Van Laethem JL, Verslype C, Scheithauer W, Shang A, Cosaert J, Moore MJ |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 5/1/2009, Vol. 27 Issue 13, p2231-2237, 7p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|